Skip to main content

Currently Skimming:

Appendix B: Methodology for Efficacy Assessment of In Vivo Malaria Therapy
Pages 151-154

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 151...
... Those who have a parasite density above a defined level are treated with a standard dose of antimalarial drug under supervision to ensure compliance. Follow-up thick blood smears are typically obtained on days 2 and 3, 7 days after initiation of treatment, and then once every 7 days for the duration of follow-up.
From page 152...
... The World Health Organization has defined standard definitions for both parasitological failure and clinical failure. The definitions differ somewhat for areas with high transmission, with differences in the protocol highlighted for areas of low/moderate transmission.
From page 153...
... RI denotes a mildly resistant response in which parasitemia declines substantially within the first 48 to 72 hours posttreatment, is apparently cleared on subsequent examinations, but recrudesces sometime during follow-up. S denotes a fully sensitive response in which parasites are cleared and patients remain parasite free for the duration of follow-up.
From page 154...
... 25 percent of the Day 0 density AND negative blood smears on every follow-up examination between Day 7 and Day 14. With follow-up periods of 14 days, it is not possible to distinguish sensitive responses from late recrudescences, and these responses are combined in the RI/S category.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.